BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Shirabe K, Yoshizumi T, Kotoh K, Furusyo N, Hida T, Oda Y, Fujioka T, Honda H. Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry. World J Gastroenterol 2016; 22(40): 8949-8955 [PMID: 27833386 DOI: 10.3748/wjg.v22.i40.8949]
URL: https://www.wjgnet.com/1007-9327/full/v22/i40/8949.htm
Number Citing Articles
1
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver diseaseThe Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
2
Monica C. Preciado-Puga, Yeniley Ruiz-Noa, Juana R. Garcia-Ramirez, Benjamin Jordan-Perez, Serafin Garnelo-Cabañas, Maria L. Lazo de la Vega-Monroy, Karen I. Gutierrez-Aguirre, Lorena R. Ibarra-Reynoso. Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measuresAnnals of Hepatology 2021; 21: 100264 doi: 10.1016/j.aohep.2020.09.008
3
Gao-Xiong Ouyang, Yu-mei Zhang, Shao-Liang Zhu, Peng Wang, Yuan Ren, Jia-Hao Li, Yu-Kai Liu, Jun Chen, Bang-De Xiang, Le-Qun Li, Jian-Yong Liu, Zhi-Ming Zhang. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinomaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31351-3